Xencor, Inc. (XNCR): Price and Financial Metrics
XNCR Price/Volume Stats
| Current price | $23.93 | 52-week high | $28.96 |
| Prev. close | $20.94 | 52-week low | $16.49 |
| Day low | $20.85 | Volume | 1,875,509 |
| Day high | $24.42 | Avg. volume | 699,972 |
| 50-day MA | $21.94 | Dividend yield | N/A |
| 200-day MA | $20.89 | Market Cap | 1.48B |
XNCR Stock Price Chart Interactive Chart >
Xencor, Inc. (XNCR) Company Bio
Xencor Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases and cancer. The company was founded in 1997 and is based in Monrovia, California.
Latest XNCR News From Around the Web
Below are the latest news stories about XENCOR INC that investors may wish to consider to help them evaluate XNCR as an investment opportunity.
Xencor (NASDAQ:XNCR) shareholders are up 7.7% this past week, but still in the red over the last three yearsXencor, Inc. ( NASDAQ:XNCR ) shareholders should be happy to see the share price up 19% in the last month. But that is... |
Xencor to Present at the Piper Sandler 35th Annual Healthcare ConferencePASADENA, Calif., November 21, 2023--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases, today announced that company management will present at the Piper Sandler 35th Annual Healthcare Conference in New York City on Tuesday, November 28, 2023, at 8:00 a.m. ET / 11:00 a.m. PT. |
Things Look Grim For Xencor, Inc. (NASDAQ:XNCR) After Today's DowngradeOne thing we could say about the analysts on Xencor, Inc. ( NASDAQ:XNCR ) - they aren't optimistic, having just made a... |
Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call TranscriptXencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript November 8, 2023 Operator: Good afternoon and thank you for standing by. Welcome to Xencor’s Third Quarter 2023 Conference Call. Please be advised that this call is going to be recorded at the company’s request. Now, I would like to turn the call over to your speaker […] |
We're Not Very Worried About Xencor's (NASDAQ:XNCR) Cash Burn RateWe can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining... |
XNCR Price Returns
| 1-mo | 9.17% |
| 3-mo | 25.55% |
| 6-mo | 29.70% |
| 1-year | -9.42% |
| 3-year | -43.77% |
| 5-year | -26.82% |
| YTD | 12.72% |
| 2023 | -18.47% |
| 2022 | -35.09% |
| 2021 | -8.04% |
| 2020 | 26.87% |
| 2019 | -4.89% |
Continue Researching XNCR
Want to see what other sources are saying about Xencor Inc's financials and stock price? Try the links below:Xencor Inc (XNCR) Stock Price | Nasdaq
Xencor Inc (XNCR) Stock Quote, History and News - Yahoo Finance
Xencor Inc (XNCR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...